Zhen Gooi

Zhen Gooi

University of Chicago

H-index: 17

North America-United States

About Zhen Gooi

Zhen Gooi, With an exceptional h-index of 17 and a recent h-index of 16 (since 2020), a distinguished researcher at University of Chicago,

His recent articles reflect a diverse array of research interests and contributions to the field:

Neutrophil-to-Lymphocyte Ratio Kinetics and Survival with Neoadjuvant Immuno-chemotherapy and Response-Stratified Chemoradiation in Locoregionally Advanced Head and Neck Cancer

185 Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer

886P Prospective evaluation of dynamic changes of cell-free HPV-DNA (cfHPV-DNA) in locoregional HPV associated (HPV+) oropharyngeal cancer (OPC) treated with neoadjuvant …

Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer

Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation Trials

Definitive Chemoradiotherapy for Salivary Gland Cancers

Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma …

Randomized phase I/II trial of TheraT vectors expressing HPV16 specific antigens with neoadjuvant chemotherapy followed by transoral robotic surgery (TORS) or risk/response …

Zhen Gooi Information

University

Position

Assistant Professor

Citations(all)

1162

Citations(since 2020)

891

Cited By

603

hIndex(all)

17

hIndex(since 2020)

16

i10Index(all)

25

i10Index(since 2020)

24

Email

University Profile Page

Google Scholar

Top articles of Zhen Gooi

Neutrophil-to-Lymphocyte Ratio Kinetics and Survival with Neoadjuvant Immuno-chemotherapy and Response-Stratified Chemoradiation in Locoregionally Advanced Head and Neck Cancer

International Journal of Radiation Oncology, Biology, Physics

2024/4/1

185 Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer

Radiotherapy and Oncology

2024/3/1

886P Prospective evaluation of dynamic changes of cell-free HPV-DNA (cfHPV-DNA) in locoregional HPV associated (HPV+) oropharyngeal cancer (OPC) treated with neoadjuvant …

Annals of Oncology

2023/10/1

Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation Trials

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

Definitive Chemoradiotherapy for Salivary Gland Cancers

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma …

2023/6/1

Randomized phase I/II trial of TheraT vectors expressing HPV16 specific antigens with neoadjuvant chemotherapy followed by transoral robotic surgery (TORS) or risk/response …

2023/6/1

Abstract A085: Racial differences in organ preservation with definitive chemoradiotherapy among patients with T4 laryngeal squamous cell carcinoma

2023/1/1

Feasibility of clinical evaluation of individuals with increased risk for HPV‐associated oropharynx cancer

Head & neck

2023/1

Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases

Diagnostics

2022/9/5

Aditya Juloori
Aditya Juloori

H-Index: 10

Zhen Gooi
Zhen Gooi

H-Index: 13

Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits

Cureus

2022/7/31

Swallowing and quality-of-life outcomes of response adaptive de-escalated therapy following nivolumab-based induction for HPV+ oropharyngeal cancer.

2022/6/1

Nivolumab-based induction chemoimmunotherapy and PD-L1 expression in locoregionally advanced HPV-associated oropharyngeal squamous cell carcinoma.

2022/6/1

Omission of the Pathologic Node-Negative Neck From Postoperative Radiation Therapy for Oral Cavity Cancer

International Journal of Radiation Oncology, Biology, Physics

2022/4/1

Molecular drivers of oral cavity squamous cell carcinoma in non-smoking and non-drinking patients: what do we know so far?

2022/2/2

Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response …

BMC cancer

2022/12

International Guidelines for Intratumoral and Intranodal Injection of NTBXR3 Nanoparticles in Head and Neck Cancers

International Journal of Radiation Oncology, Biology, Physics

2022/11/1

Assessment of tumor burden and response by RECIST vs. volume change in HPV+ oropharyngeal cancer–an exploratory analysis of prospective trials

International Journal of Radiation Oncology, Biology, Physics

2022/11/1

Cell-Free HPV DNA Kinetics Predicted by Radiographic Response in Locoregional Viral-Associated Oropharyngeal Cancer Receiving Response-Adaptive Treatment–Exploratory Analysis …

International Journal of Radiation Oncology, Biology, Physics

2022/11/1

See List of Professors in Zhen Gooi University(University of Chicago)